(R)-Methyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate

Catalog No. :
ACBDQH761
CAS No. :
1369532-11-5
Molecular Formula :
C14H18N4O3
Molecular Weight :
290.32

IUPAC Name:methyl (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate

(R)-Methyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Methyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate
IUPAC Namemethyl (R)-4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate
Molecular FormulaC14H18N4O3
Molecular Weight290.32
SMILESO=C(N1CCN(C2=C([C@H](C)CC3=O)C3=NC=N2)CC1)OC
InChI KeyUVCSKPHHSWLLTB-SECBINFHSA-N
Synonym(R)-Methyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxyla
CAS No.1369532-11-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBDQH761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBDQH761 route product structure diagram
    ACBDQH7611369532-11-5
Inquiry

2. ACBDQH761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOFLU429 route compound structure diagram
    ACOFLU42950606-31-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBDQH761 route product structure diagram
    ACBDQH7611369532-11-5
Inquiry

Comments (0)